Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review (vol 43, pg 296, 2009)

被引:0
|
作者
Lin [1 ]
机构
[1] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan
关键词
D O I
10.1345/aph.1L504a
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:551 / 551
页数:1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review
    Chan, Agnes L. F.
    Leung, Henry W. C.
    Lu, Chin-Li
    Lin, Shun Jin
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 296 - 303
  • [2] Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review
    Rafar, Noor Razilah Abdul
    Hong, Yet Hoi
    Wu, David Bin-Chia
    Othman, Muhamad Faiz
    Neoh, Chin Fen
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 : 151 - 158
  • [3] COST-EFFECTIVENESS OF ADJUVANT TRASTUZUMAB FOR EARLY BREAST CANCER IN ASIA: A SYSTEMATIC REVIEW
    Rafar, Abdul N. R.
    Neoh, C. F.
    Othman, M. F.
    Hong, Y. H.
    [J]. VALUE IN HEALTH, 2018, 21 : S14 - S14
  • [4] Cost-effectiveness analysis of adjuvant therapy with trastuzumab for early breast cancer
    Wardley, Andrew M.
    Cameron, David A.
    Bell, Richard
    Erny, Samuel
    Cohen, Carole
    Geary, Una
    Walzer, Stefan
    Gyldmark, Marlene
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 95 - 96
  • [5] The cost-effectiveness issue of adjuvant trastuzumab in early breast cancer
    Norum, Jan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (12) : 1617 - 1625
  • [6] COST-EFFECTIVENESS OF ADJUVANT THERAPY WITH TRASTUZUMAB IN THE TREATMENT OF EARLY BREAST CANCER (EBC) IN ROMANIA
    Grecea, D.
    Baculea, S.
    Radu, P. C.
    Pana, B.
    Szkultecka-Debek, M.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A42 - A42
  • [7] TRASTUZUMAB IN METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES
    Andrade, T. S. D.
    Mosegui, G. B. G.
    Miranda, E. S.
    Souza, T. F. G. D.
    Vianna, C. M. D. M.
    Silva, F. V. C.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A687 - A687
  • [8] Trastuzumab in adjuvant breast cancer therapy: A model based cost-effectiveness analysis.
    Norum, J.
    Olsen, J. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 34S - 34S
  • [9] Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis
    Norum, J.
    Olsen, J. A.
    Wist, E. A.
    Lonning, P. E.
    [J]. ACTA ONCOLOGICA, 2007, 46 (02) : 153 - 164
  • [10] REVIEW OF COST EFFECTIVENESS OF TRASTUZUMAB IN EARLY BREAST CANCER
    Van Rooijen, E. M.
    Krol, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A470 - A470